Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
Details
Download: 32300051_BIB_819D81E8FA74.pdf (404.41 [Ko])
State: Public
Version: Final published version
License: CC BY-NC 4.0
State: Public
Version: Final published version
License: CC BY-NC 4.0
Serval ID
serval:BIB_819D81E8FA74
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
Title
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
Journal
Journal for immunotherapy of cancer
ISSN
2051-1426 (Electronic)
ISSN-L
2051-1426
Publication state
Published
Issued date
04/2020
Peer-reviewed
Oui
Volume
8
Number
1
Language
english
Notes
Publication types: Editorial
Publication Status: ppublish
Publication Status: ppublish
Keywords
Betacoronavirus, Coronavirus Infections/diagnostic imaging, Coronavirus Infections/drug therapy, Coronavirus Infections/immunology, Coronavirus Infections/therapy, Drug Approval, Humans, Immunologic Factors/therapeutic use, Immunotherapy, Inflammation/blood, Inflammation/therapy, Interleukin-6/agonists, Neoplasms/therapy, Pandemics, Pneumonia, Viral/diagnostic imaging, Pneumonia, Viral/drug therapy, Pneumonia, Viral/immunology, Pneumonia, Viral/therapy, Receptors, Interleukin-6/agonists, immunomodulation, inflammation mediators
Pubmed
Open Access
Yes
Create date
25/04/2020 18:59
Last modification date
15/01/2021 7:10